Suppr超能文献

乳酸/白蛋白比值与急性心肌梗死后危重症患者 28 天全因死亡率的关系。

Association between lactate/albumin ratio and 28-day all-cause mortality in critically ill patients with acute myocardial infarction.

机构信息

Department of Cardiology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Department of Medical Imaging, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Sci Rep. 2024 Oct 10;14(1):23677. doi: 10.1038/s41598-024-73788-9.

Abstract

Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide. Early identification of high-risk patients is crucial for timely interventions and improved outcomes. The lactate/albumin ratio (LAR) has been suggest as a significant correlate for assessing the risk of mortality in critically ill patients. This study aimed to utilize the American eICU Collaborative Research Database to explore the association between baseline LAR and all-cause mortality within 28 days in ICU of critically ill patients diagnosed with AMI. We conducted a retrospective cohort study of 989 AMI patients from the eICU Collaborative Research Database. Patients were included based on ICD-9 code 410 and the universal definition of AMI. LAR was calculated as the ratio of baseline lactate to albumin levels within the first 24 h of ICU admission. The outcome was all-cause mortality within 28 days after ICU admission. Multivariable logistic regression models were used to evaluate the independent association between LAR and the risk of death, adjusting for potential confounders including demographics, comorbidities, vital signs, and laboratory parameters. Subgroup analyses and nonlinear modeling were performed to further explore the relationship. Of the 989 AMI patients, 171 (17.3%) died within 28 days after ICU admission. Patients who died had significantly higher LAR compared to survivors (1.66 vs. 0.96, p < 0.001). Multivariable analysis showed that each unit increase in LAR was associated with a 2.15-fold higher risk of all-cause mortality within 28 days after ICU admission (95% CI: 1.64-2.83, p < 0.001). Subgroup analyses confirmed the consistent association across different patient characteristics. Nonlinear modeling revealed a threshold effect, where LAR above 2.15 was no longer significantly associated with mortality. Kaplan-Meier survival analysis demonstrated lower survival probabilities for patients with higher LAR(1.0526-5.8235). The findings suggest that a higher LAR was associated with an increased risk of 28-day all-cause mortality for critically ill patients with AMI after ICU admission.

摘要

急性心肌梗死(AMI)是全球发病率和死亡率的主要原因。早期识别高危患者对于及时干预和改善预后至关重要。乳酸/白蛋白比值(LAR)已被提出作为评估危重症患者死亡率的重要相关指标。本研究旨在利用美国 eICU 协作研究数据库探讨 ICU 内诊断为 AMI 的危重症患者基线 LAR 与 28 天内全因死亡率之间的关系。我们对 eICU 协作研究数据库中的 989 例 AMI 患者进行了回顾性队列研究。根据 ICD-9 编码 410 和 AMI 的通用定义纳入患者。LAR 计算为 ICU 入院后 24 小时内基线乳酸与白蛋白水平的比值。结局为 ICU 入院后 28 天内的全因死亡率。多变量逻辑回归模型用于评估 LAR 与死亡风险之间的独立关联,调整了包括人口统计学、合并症、生命体征和实验室参数在内的潜在混杂因素。进行了亚组分析和非线性建模以进一步探讨这种关系。在 989 例 AMI 患者中,171 例(17.3%)在 ICU 入院后 28 天内死亡。与幸存者相比,死亡患者的 LAR 显著更高(1.66 比 0.96,p<0.001)。多变量分析显示,LAR 每增加一个单位,与 ICU 入院后 28 天内全因死亡率增加 2.15 倍相关(95%CI:1.64-2.83,p<0.001)。亚组分析证实了不同患者特征之间的一致性关联。非线性建模显示,LAR 超过 2.15 后与死亡率不再显著相关。Kaplan-Meier 生存分析表明,LAR 较高的患者生存率较低(1.0526-5.8235)。研究结果表明,对于 ICU 入院后诊断为 AMI 的危重症患者,较高的 LAR 与 28 天内全因死亡率增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da70/11466948/614095b6407b/41598_2024_73788_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验